A research study to look into the long-term effect on weight loss of CagriSema in people with obesity (NCT06780449) Summary: This is an ongoing Phase 3 trial (as of current knowledge) designed to evaluate the long-term efficacy and safety of once-weekly CagriSema in people living with obesity
Disclaimer: This website connects patients with licensed healthcare providers who can evaluate medical conditions and prescribe medications when appropriate
Metabolism: Clinical and Experimental
Expired codes move out of the active table
Pentosan PPS Injectable LEARN MORE Pentosan PPS Injectable supports joint repair and cartilage regeneration, reduces inflammation, alleviates pain associated with arthritis or connective tissue damage, and promotes long-term joint health and mobility
The introduction of nasal spray delivery of peptides is associated with improved bioavailability, shorter latency to physiological levels, and lower inter-dose variability
